Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study.
暂无分享,去创建一个
J. Woo | Jeong Hyun Park | C. Chung | Sang Jin Kim | S. H. Kim | K. Ko | H. Jang | D. Choi | S. Kim | Yong soo Park | Yongsoo Park | D. Kim | Sun Hwa Kim | Sang Jin Kim